KAMRAN AHRAR to Catheter Ablation
This is a "connection" page, showing publications KAMRAN AHRAR has written about Catheter Ablation.
Connection Strength
4.617
-
Imaging of the thorax after percutaneous thermal ablation of lung malignancies. Clin Radiol. 2022 01; 77(1):31-43.
Score: 0.540
-
MRI-Guided Interventions in Musculoskeletal System. Top Magn Reson Imaging. 2018 Jun; 27(3):129-139.
Score: 0.433
-
Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel on Renal Sympathetic Denervation. J Vasc Interv Radiol. 2014 Apr; 25(4):497-509.
Score: 0.324
-
Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2011 Jul; 22(7):924-7.
Score: 0.264
-
Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2010 May; 21(5):690-5.
Score: 0.245
-
Nephron-sparing probe ablative therapy: long-term outcomes. Curr Opin Urol. 2008 Mar; 18(2):150-6.
Score: 0.213
-
Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007 Sep; 18(9):1186-91.
Score: 0.206
-
Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices. J Vasc Interv Radiol. 2007 Jul; 18(7):929-35.
Score: 0.203
-
Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors. Expert Rev Anticancer Ther. 2006 Dec; 6(12):1735-44.
Score: 0.195
-
Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol. 2005 Jul; 185(1):86-8.
Score: 0.177
-
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May; 16(5):679-88.
Score: 0.175
-
2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2004 Sep; 15(9):901-5.
Score: 0.167
-
The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors. Curr Oncol Rep. 2004 Jul; 6(4):315-20.
Score: 0.165
-
Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol. 2003 Aug; 14(8):1037-43.
Score: 0.155
-
A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging. Eur J Surg Oncol. 2021 02; 47(2):311-316.
Score: 0.126
-
Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases. J Vasc Interv Radiol. 2018 03; 29(3):395-403.e1.
Score: 0.106
-
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017 May; 104(6):760-768.
Score: 0.099
-
Predicting and Determining the Success of Percutaneous Ablation. J Urol. 2016 07; 196(1):7-8.
Score: 0.093
-
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013 May; 111(6):997-1005.
Score: 0.075
-
Surgical management and minimally invasive approaches for the treatment of metastatic sarcoma. Am Soc Clin Oncol Educ Book. 2013; 457-64.
Score: 0.074
-
A spectrum of nerve injury after thermal ablation: a report of four cases and review of the literature. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1427-35.
Score: 0.073
-
Development of a research agenda for percutaneous renal tumor ablation: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2010 Dec; 21(12):1807-16.
Score: 0.064
-
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol. 2010 Nov; 184(5):1882-7.
Score: 0.063
-
Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010 Feb 15; 116(4):989-97.
Score: 0.061
-
Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010 Feb; 105(4):496-500.
Score: 0.059
-
Is radiofrequency ablation safe for solitary kidneys? Urology. 2007 May; 69(5):819-23; discussion 823.
Score: 0.050
-
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006 Nov; 176(5):1973-7.
Score: 0.049
-
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004 Jan 15; 22(2):300-6.
Score: 0.040
-
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol. 2003 Jul; 170(1):178-9.
Score: 0.038
-
The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018 10; 1(5):395-402.
Score: 0.028
-
Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol. 2017 Jun; 43(6):1040-1049.
Score: 0.025
-
Ablative therapies in renal cell carcinoma. Minerva Urol Nefrol. 2011 Sep; 63(3):237-50.
Score: 0.017
-
Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol. 2006 Aug; 17(8):1235-49; quiz 1250.
Score: 0.012